Dialytix provides the first kidney disease platform focused on providing a functional data science ecosystem with state-of-the-art AI technologies for the treatment and research of Acute Kidney Disease.
We implement an innovative federated learning paradigm which does not centralize data so it maintains privacy.
A typical surgical patient with AKI costs 159% more than one without AKI. Without better data we’ll continue to see more readmissions and higher acuity and mortality rates.
A healthy kidney filters toxins and fluids by itself, but CRRT helps replace this process by removing toxins and excess fluids.
This creates greater hemodynamic stability, better fluid management, greater solute control, less bleeding, and more.
Better utilization of multi-modal data from EHRs and CRRT machines result in more precise delivery and decision making.
Deeper insight into sub-phenotypes of patients with differing mortality risk will greatly benefit clinical trials.
Get in touch to schedule a call and learn more.